Bone Marrow Failure

The inability of the bone marrow elements.

• Publication year

  2020

• Venue

  Definitions

• Publication date

  2020-02-08

• Fields of study

  Medicine

• Identifiers
  DOI 10.1201/b14737-8
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Aplastic Anemia

  2020cited by this paper
• Fanconi Anemia

  2019cited by this paper
• Acquired Disorders of Red Cell, White Cell, and Platelet Production

  2018cited by this paper
• [Anemia of chronic disease].

  2017cited by this paper
• A never-ending story: the steadily growing family of the FA and FA-like genes

  2017cited by this paper
• The genomics of inherited bone marrow failure: from mechanism to the clinic

  2017cited by this paper
• Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia

  2017cited by this paper
• Bone marrow transplantation versus immunosuppressive therapy in patients with acquired severe aplastic anemia

  2016cited by this paper
• Alternative donor hematopoietic cell transplantation for Fanconi anemia.

  2015cited by this paper
• Volume index

  2015cited by this paper
• Congenital dyserythropoietic anemias: molecular insights and diagnostic approach.

  2013cited by this paper
• Endocrine evaluation of children with and without Shwachman-Bodian-Diamond syndrome gene mutations and Shwachman-Diamond syndrome.

  2013cited by this paper
• Über einen Fall von Anämie mit Bemerkungen über regenerative Veränderungen des Knochenmarks

  2013cited by this paper
• Congenital dyserythropoietic anemia type III (CDA III) is caused by a mutation in kinesin family member, KIF23.

  2013cited by this paper
• How I treat acquired aplastic anemia.

  2012cited by this paper
• Inherited bone marrow failure syndromes

  2011cited by this paper
• Ribosomal protein gene deletions in Diamond-Blackfan anemia.

  2011cited by this paper
• The ribosomal basis of diamond‐blackfan anemia: mutation and database update

  2010cited by this paper
• Pathophysiology and management of inherited bone marrow failure syndromes.

  2010cited by this paper
• Aplastic anemia and concomitant autoimmune diseases

  2009cited by this paper
• Diamond-Blackfan anemia: diagnosis, treatment, and molecular pathogenesis.

  2009cited by this paper
• Shwachman-Diamond syndrome: a review of the clinical presentation, molecular pathogenesis, diagnosis, and treatment.

  2009cited by this paper
• Diagnosis and management of acquired pure red cell aplasia.

  2009cited by this paper
• Hematopoietic growth factors in aplastic anemia patients treated with immunosuppressive therapy-systematic review and meta-analysis

  2009cited by this paper
• Cancer in dyskeratosis congenita.

  2009cited by this paper
• The congenital dyserythropoietic anemias.

  2009cited by this paper
• Codanin-1, the protein encoded by the gene mutated in congenital dyserythropoietic anemia type I (CDAN1), is cell cycle-regulated

  2009cited by this paper
• Systematic review: hepatitis‐associated aplastic anaemia – a syndrome associated with abnormal immunological function

  2009cited by this paper
• Diagnosis of Fanconi anemia in patients with bone marrow failure

  2009cited by this paper
• Use of a FLAER-based WBC assay in the primary screening of PNH clones.

  2009cited by this paper
• Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II

  2009cited by this paper
• Telomere maintenance and human bone marrow failure.

  2008cited by this paper
• Inherited aplastic anaemias/bone marrow failure syndromes.

  2008cited by this paper
• NQO1, MPO, CYP2E1, GSTT1 and GSTM1 polymorphisms and biological effects of benzene exposure--a literature review.

  2008cited by this paper
• Mitotic spindle destabilization and genomic instability in Shwachman-Diamond syndrome.

  2008cited by this paper
• Mutations in the SBDS gene in acquired aplastic anemia.

  2007cited by this paper
• Transient Erythroblastopenia of Childhood in Siblings: Case Report and Review of the Literature

  2007cited by this paper
• Making COPII coats.

  2007cited by this paper
• Cytokine gene polymorphisms in acquired bone marrow failure

  2007cited by this paper
• Functional characterization of natural telomerase mutations found in patients with hematologic disorders.

  2007cited by this paper
• Deficient CD4+ CD25+ FOXP3+ T regulatory cells in acquired aplastic anemia.

  2007cited by this paper
• Mature erythrocyte parameters as new markers of functional iron deficiency in haemodialysis: sensitivity and specificity.

  2007cited by this paper
• Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita.

  2007cited by this paper
• Granulocyte-stimulating factor and severe aplastic anemia: a survey by the European Group for Blood and Marrow Transplantation (EBMT).

  2007cited by this paper
• Improving clinical care and elucidating the pathophysiology of Diamond Blackfan anemia: An update from the Diamond Blackfan Anemia Registry

  2006cited by this paper
• The Fanconi Anemia Pathway of Genomic Maintenance

  2006cited by this paper
• Minor population of CD55-CD59- blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemia.

  2006cited by this paper
• Assessing iron status: beyond serum ferritin and transferrin saturation.

  2006cited by this paper
• T-bet, a Th1 transcription factor, is up-regulated in T cells from patients with aplastic anemia.

  2006cited by this paper
• Retreatment with rabbit anti‐thymocyte globulin and ciclosporin for patients with relapsed or refractory severe aplastic anaemia

  2006cited by this paper
• Current concepts in the pathophysiology and treatment of aplastic anemia.

  2006cited by this paper
• Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group.

  2005cited by this paper
• Specific antibodies to moesin, a membrane-cytoskeleton linker protein, are frequently detected in patients with acquired aplastic anemia.

  2005cited by this paper
• Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia.

  2005cited by this paper
• Clinical spectrum of myelophthisis in cancer patients

  2004cited by this paper
• Genomic instability in bone marrow failure syndromes

  2004cited by this paper
• Congenital dyserythropoietic anemias: epidemiology, clinical significance, and progress in understanding their pathogenesis

  2004cited by this paper
• Diazepam-binding inhibitor-related protein 1: a candidate autoantigen in acquired aplastic anemia patients harboring a minor population of paroxysmal nocturnal hemoglobinuria-type cells.

  2004cited by this paper
• Increased risk for aplastic anemia and myelodysplastic syndrome in individuals lacking glutathione S‐transferase genes

  2004cited by this paper
• Gene expression profiling in CD34 cells to identify differences between aplastic anemia patients and healthy volunteers.

  2004cited by this paper
• In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing.

  2004cited by this paper
• Autoantibodies frequently detected in patients with aplastic anemia.

  2003cited by this paper
• Cancer in Fanconi anemia, 1927–2001

  2003cited by this paper
• Fanconi anaemia

  2003cited by this paper
• Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia.

  2003cited by this paper
• Abnormal telomere metabolism in Fanconi's anaemia correlates with genomic instability and the probability of developing severe aplastic anaemia

  2003cited by this paper
• Cancer incidence in persons with Fanconi anemia.

  2003cited by this paper
• The role of occupational and environmental exposures in the aetiology of acquired severe aplastic anaemia: a case control investigation

  2003cited by this paper
• A 20-year perspective on the International Fanconi Anemia Registry (IFAR).

  2003cited by this paper
• Shwachman–Diamond Syndrome

  2002cited by this paper
• Congenital dyserythropoietic anemia type I is caused by mutations in codanin-1.

  2002cited by this paper
• Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia.

  2002cited by this paper
• Aplastic anemia in the orient

  2002cited by this paper
• Hypoplastic myelodysplastic syndromes can be distinguished from acquired aplastic anaemia by bone marrow stem cell expression of the tumour necrosis factor receptor

  2002cited by this paper
• Pregnancy Associated Aplastic Anemia--A Series of 10 Cases with Review of Literature

  2002cited by this paper
• HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome.

  2002cited by this paper
• Telomere length in leukocyte subpopulations of patients with aplastic anemia.

  2001cited by this paper
• Role of uremic toxins in exacerbating anemia in renal failure.

  2001cited by this paper
• Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome.

  2001cited by this paper
• Late clonal diseases of treated aplastic anemia.

  2000cited by this paper
• Hematopoietic cell destruction by immune mechanisms in acquired aplastic anemia.

  2000cited by this paper
• Progressive telomere shortening in aplastic anemia.

  1998cited by this paper
• Hematopoietic growth factors and marrow stroma in aplastic anemia.

  1998cited by this paper
• The pathophysiology of acquired aplastic anemia.

  1997cited by this paper
• A severe and consistent deficit in marrow and circulating primitive hematopoietic cells (long-term culture-initiating cells) in acquired aplastic anemia.

  1996cited by this paper
• Rheumatologic manifestations of renal disease.

  1996cited by this paper
• Flt3 ligand level reflects hematopoietic progenitor cell function in aplastic anemia and chemotherapy-induced bone marrow aplasia.

  1996cited by this paper
• Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemia

  1995cited by this paper
• Interferon-gamma and tumor necrosis factor-alpha suppress both early and late stages of hematopoiesis and induce programmed cell death.

  1995cited by this paper
• Increased apoptosis in aplastic anemia bone marrow progenitor cells: possible pathophysiologic significance.

  1995cited by this paper
• Immunosuppressive therapy in bone marrow aplasia: the stroma functions normally to support hematopoiesis.

  1995cited by this paper
• An increased HLA DR2 frequency is seen in aplastic anemia patients.

  1994cited by this paper
• Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT * SAA Working Party

  1988cited by this paper
• Incidence of aplastic anemia: the relevance of diagnostic criteria. By the International Agranulocytosis and Aplastic Anemia Study.

  1987cited by this paper
• Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality.

  1976cited by this paper
• Bone Marrow Graft in Man after Conditioning by Antilymphocytic Serum*

  1970cited by this paper

• Congenital Disorders of Red Blood Cells.

  2022cites this paper
• The Sirt1 activator resveratrol improved hematopoiesis in pancytopenia mice induced by irradiation.

  2019cites this paper